Saison Information Systems Establishes EMEA Operations Base
6.7.2017 05:43 | Business Wire
Saison Information Systems Co., Ltd. (JASDAQ:9640) (Headquarters: Tokyo, Japan; CEO: Kazuhiro Uchida) opened an office in London on July 6, 2017. It will function as an operations base for servicing the EMEA region, with an initial focus on sales of HULFT, the company’s highly successful managed file transfer (MFT) middleware.
After HULFT gained an overwhelmingly dominant share of its segment in the Japanese market, Saison Information Systems has been working to expand its global footprint by establishing overseas subsidiaries and opening offices as follows.
- China: HULFT China Co., Ltd. was established in May 2012 and has offices in Shanghai and Beijing.
- ASEAN: HULFT Pte. Ltd. was established in Apr. 2015 and has an office in Singapore.
- North America: HULFT Inc. was established in Apr. 2016 and has an office in San Mateo, California.
These efforts have born results, and as of the end of March 2017:
- HULFT had 189,600 HULFT licenses in use by 8,700 companies in 43 countries worldwide; and,
- DataSpider Servista had been installed by over 3,000 companies.
The decision was made to set up in the EMEA region to meet the needs of end users and partners there.
• Name: Saison Information Systems Co., Ltd. EMEA Office
• Location: 6th Floor, First Central 200, 2 Lakeside Drive, London NW 10 7FQ, United Kingdom
• Establishment: July 6, 2017
• Contact: SalesSupport_EMEA@hulft.com
• Activities: Research, marketing, and liaison with companies located in the EMEA region.
Compatible with an ever-growing range of platforms since its launch in 1993, HULFT is managed file transfer (MFT) middleware equipped with all the functionality enterprises need to share data between business systems. As of March 2017, there are 189,600 HULFT licenses in use by 8,700 companies in 43 countries worldwide, spanning a broad range of industries. In addition to sending, receiving and managing file transfer jobs, HULFT also includes peripheral functions essential to transferring files, including security and integration of data before and after transfer.
Product Details: https://www.hulft.com/en/hulft-mft/
About DataSpider Servista
As of March 2017, DataSpider Servista has been installed by over 3,000 companies. In Japan, it has been ranked No. 1 in customer satisfaction for four years running*. Its GUI enables quick and easy setup without the need for coding. Its many adapters can connect a wide variety of systems, applications, databases, and other data sources hosted either on-premise or in the cloud. It can be used to automate a broad range of processes, thereby greatly improving an organization’s operational efficiency.
Product Details: https://www.hulft.com/en/dataspider-servista/
* Source: EAI Software survey by Nikkei BP Consulting, April 2017.
Saison Information Systems Co., Ltd.
- Headquarters: Sunshine 60 (21F), 3-1-1 Higashi-Ikebukuro, Toshima-ku, Tokyo 170-6021, Japan
- Established: September 1970
- President: Kazuhiro Uchida (President & CEO)
- Website: http://home.saison.co.jp/english/
* HULFT and related product names are registered trademarks or trademarks of Saison Information Systems Co., Ltd.
* DataSpider and DataSpider Servista are registered trademarks or trademarks of Appresso K.K.
* Other company names, product names and service names are registered trademarks or trademarks of their respective companies.
Saison Information Systems Co., Ltd.
Masaaki Takayama, +81-3-3988-5301
Akane Toyota, +81-3-3988-3477
Corporate Planning Department
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Boehringer Ingelheim starts clinical study on interchangeability between its adalimumab biosimilar candidate and HUMIRA®27.7.2017 16:00 | Tiedote
Boehringer Ingelheim announced today that the first patient has been enrolled into its VOLTAIRE-X interchangeability study. The goal of the study is to demonstrate that BI 695501 is interchangeable with the U.S.-marketed formulation of Humira®* 40mg/0.8mL. This is the first study in the U.S. to investigate an interchangeability designation for an adalimumab biosimilar candidate. The study will compare the pharmacokinetics and clinical outcomes between patients receiving Humira® continuously, versus those who switch repeatedly between Humira® and BI 695501, Boehringer Ingelheim’s adalimumab biosimilar candidate.1 The study will also assess safety, immunogenicity and efficacy.1 “We are pleased that the first patient has now been enrolled in VOLTAIRE-X, and look forward to continued recruitment and patient follow-up,” said Ivan Blanarik, Senior Vice President and Head of
Acxiom Launches Connected Spaces27.7.2017 15:30 | Tiedote
Today, Acxiom® (Nasdaq: ACXM), in collaboration with Adobe, announced the launch of Connected Spaces, a global solution aimed at delivering more relevant omnichannel experiences to customers. Connected Spaces is designed to revolutionise customer experience and business returns for retail, travel and leisure locations such as airports, malls, sports stadiums, concert arenas and resorts. A pioneering example is Heathrow airport. Heathrow is able to deliver more relevant communications to customers in real-time as part of its overall engagement strategy and is already generating exceptional results including an increase in spend of 20-25 percent for engaged customers. Common to airports, malls and the like is a high footfall of consumers who intend to visit multiple concession, franchise, or subcontracted brands operating in their environments. This can translate to a relative
Watch BizWireTV: Helix Brings DNA Kits to the Public and Michael Kors Gets Ready to Buy Jimmy Choo27.7.2017 15:08 | Tiedote
On the latest BizWireTV, catch the latest Quick Biz Hits. Also see what’s happening in the startup world with the Accelerator Report, featuring the VC Watch and this week’s Startup Standout. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170727005456/en/ BizWireTV is hosted by Jordyn Rolling (Photo: Business Wire) Now you can watch BizWireTV, and the latest breakthroughs in tech from the biggest brands, on any screen you want by downloading the new app through the Apple TV and iPhone App Store and Google Play for Android devices. Top of the Wire Helix launches first online consumer marketplace for DNA-powered products that offer insights on ancestry, entertainment, family, fitness, health and nutrition. Watch BizWireTV to
European Commission Grants Orphan Drug Designation to Allena Pharmaceuticals’ Investigational Therapy for the Treatment of Primary Hyperoxaluria27.7.2017 14:05 | Tiedote
Allena Pharmaceuticals, Inc., a specialty biopharmaceutical company dedicated to bringing first in class, specific, non-absorbed, oral enzyme therapeutics to patients with serious renal, urologic and orphan diseases, announced today that the European Commission has granted orphan drug designation to Allena’s investigational product ALLN-177, Bacillus subtilis oxalate decarboxylase, for the treatment of primary hyperoxaluria (PH). The orphan designation was granted to Allena Pharmaceuticals Ireland Limited, a subsidiary of Allena Pharmaceuticals, Inc. Allena’s lead compound ALLN-177, is being developed to treat patients with severe hyperoxaluria, a condition characterized by markedly elevated urinary oxalate excretion. PH, a type of severe hyperoxaluria, is a rare genetic disorder caused by endogenous overproduction of oxalate by the liver that can result in kidney stone disease, kidney
Subscription Period for Superior Industries’ Tender of UNIWHEELS AG’s Shares to Close Monday, July 31, 201727.7.2017 09:00 | Tiedote
Superior Industries International, Inc. (NYSE:SUP), one of the world’s largest manufacturers of aluminum wheels, reiterated today that the subscription period for the tender offer to acquire all remaining outstanding shares of UNIWHEELS AG (“UNIWHEELS”) will close Monday, July 31, 2017. On June 30, 2017, Superior announced it had commenced a tender offer to acquire the remaining 954,920 shares held by the public shareholders, which represents approximately 7.7% of the total outstanding shares of UNIWHEELS, for cash consideration of 247.87zl per share. Superior acquired the other approximately 92.3% of the outstanding shares through a tender offer that was settled on May 30, 2017, where the public shareholders also received cash consideration of 247.87zl per share. Following the settlement of the tender offer, Superior will finalize the proceedings to delist UNIWHEELS’ common stock from
Ipsen Delivers Strong Sales Growth of 18.8%1 in the First Half of 2017 and Upgrades Its Guidance for Full Year 201727.7.2017 08:00 | Tiedote
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced financial results for the first half of 2017. H1 2017 Highlights Strong operating performance of 18.8%1 Group sales growth and Core Operating Income margin improvement by 1.2 points to 26.2% of sales Specialty Care sales growth of 23.1%1 reflects continued Somatuline® momentum and includes contribution of key new products Cabometyx® and Onivyde® Consumer Healthcare sales growth of 1.3%1 including contribution of newly acquired products Upgraded full year 2017 guidance of Specialty Care sales growth greater than 24.0%1, slight growth1 of Consumer Healthcare sales, and Core Operating Income margin greater than 25.0% o
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme